$2.30
▲ $0.09 (+4.1%)
AYTU
Aytu BioPharma Inc.
Investor Score
50C-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
62
Technical
31
Fundamental
59
Growth
38
Fair Value
50
News
58
Quality
50
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.